ロード中...
Targeting interleukin 4 receptor α: A new approach to the treatment of cutaneous autoimmune bullous diseases?
Bullous pemphigoid, mucous membrane pemphigoid, and pemphigus vulgaris are different cutaneous autoimmune blistering diseases, with complex pathogenic mechanisms. In all of them, a type‐2 response is thought to have a central role. Interleukin 4 and Interleukin 13 are crucial cytokines in type‐2 res...
保存先:
| 出版年: | Dermatol Ther |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7154653/ https://ncbi.nlm.nih.gov/pubmed/31863534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dth.13190 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|